메뉴 건너뛰기




Volumn 21, Issue 4, 2003, Pages 588-592

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: An Intergroup trial (E1193)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PACLITAXEL; ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

EID: 0037441856     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.013     Document Type: Article
Times cited : (629)

References (21)
  • 1
    • 0026354712 scopus 로고
    • Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer
    • Holmes FA, Walters RS, Theriault RL, et al: Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797-1805, 1991
    • (1991) J Natl Cancer Inst , vol.83 , pp. 1797-1805
    • Holmes, F.A.1    Walters, R.S.2    Theriault, R.L.3
  • 2
    • 0027436248 scopus 로고
    • Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
    • Reichman BS, Seidman AD, Crown JPA, et al: Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 11:1943-1951, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 1943-1951
    • Reichman, B.S.1    Seidman, A.D.2    Crown, J.P.A.3
  • 5
    • 0015462030 scopus 로고
    • Combination cancer therapy: Presidential address
    • Frei E III: Combination cancer therapy: Presidential address. Cancer Res 32:2593-2607, 1972
    • (1972) Cancer Res , vol.32 , pp. 2593-2607
    • Frei III, E.1
  • 6
    • 0009621227 scopus 로고    scopus 로고
    • Combination chemotherapy
    • Perry M ed, ed 2, Baltimore, Williams & Wilkins
    • Friedland M: Combination chemotherapy, in Perry M (ed): The Chemotherapy Source Book (ed 2). Baltimore, Williams & Wilkins, 1997, pp 101-107
    • (1997) The Chemotherapy Source Book , pp. 101-107
    • Friedland, M.1
  • 7
    • 0007831904 scopus 로고
    • Response of advanced breast carcinoma to the combination of the antimetabolite methotrexate and the alkylating agent thio-TEPA
    • Greenspan E, Fieber M, Lesnick G, et al: Response of advanced breast carcinoma to the combination of the antimetabolite methotrexate and the alkylating agent thio-TEPA. J Mt Sinai Hosp 30:246-267, 1963
    • (1963) J Mt Sinai Hosp , vol.30 , pp. 246-267
    • Greenspan, E.1    Fieber, M.2    Lesnick, G.3
  • 8
    • 0017141035 scopus 로고
    • Combination chemotherapy for metastatic breast carcinoma
    • Canellos G, Pocock S, Taylor SI, et al: Combination chemotherapy for metastatic breast carcinoma. Cancer 38:1882-1886, 1976
    • (1976) Cancer , vol.38 , pp. 1882-1886
    • Canellos, G.1    Pocock, S.2    Taylor, S.I.3
  • 9
    • 0016689884 scopus 로고
    • Chemotherapy of advanced breast cancer: A controlled randomized trial of cyclophosphamide versus a four-drug combination
    • Rubens R, Knight R, Hayward J: Chemotherapy of advanced breast cancer: A controlled randomized trial of cyclophosphamide versus a four-drug combination. Br J Cancer 32:730-736, 1975
    • (1975) Br J Cancer , vol.32 , pp. 730-736
    • Rubens, R.1    Knight, R.2    Hayward, J.3
  • 10
    • 0019198626 scopus 로고
    • Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: A randomized study
    • Carmo-Pereira J, Oliveira Costa F, Henreiques E: Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: A randomized study. Eur J Cancer 16:1621-1625, 1980
    • (1980) Eur J Cancer , vol.16 , pp. 1621-1625
    • Carmo-Pereira, J.1    Oliveira Costa, F.2    Henreiques, E.3
  • 11
    • 0021038747 scopus 로고
    • Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer
    • Steiner R, Stewart JF, Cantwell BJM, et al: Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol 19:1553, 1983
    • (1983) Eur J Cancer Clin Oncol , vol.19 , pp. 1553
    • Steiner, R.1    Stewart, J.F.2    Cantwell, B.J.M.3
  • 12
    • 0022444593 scopus 로고
    • Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: A randomized study
    • Andersson M, Daugaard S, von der Maase H, et al: Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: A randomized study. Cancer Treat Rep 70:1181-1186, 1986
    • (1986) Cancer Treat Rep , vol.70 , pp. 1181-1186
    • Andersson, M.1    Daugaard, S.2    von der Maase, H.3
  • 13
    • 0022897407 scopus 로고
    • Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trial
    • Gundersen S, Kvinnsland S, Klepp O, et al: Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trial. Eur J Cancer Clin Oncol 22:1431-1434, 1986
    • (1986) Eur J Cancer Clin Oncol , vol.22 , pp. 1431-1434
    • Gundersen, S.1    Kvinnsland, S.2    Klepp, O.3
  • 14
    • 0023514431 scopus 로고
    • The effect on survival of initial chemotherapy in advanced breast cancer: Polychemotherapy versus single drug
    • Ahmann D, Schaid D, Bisel H, et al: The effect on survival of initial chemotherapy in advanced breast cancer: Polychemotherapy versus single drug. J Clin Oncol 5:1928-1932, 1987
    • (1987) J Clin Oncol , vol.5 , pp. 1928-1932
    • Ahmann, D.1    Schaid, D.2    Bisel, H.3
  • 15
    • 0023763034 scopus 로고
    • VP-16 + Adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A Southwest Oncology Group study
    • Vaughn C, Green S, O'Bryan R, et al: VP-16 + Adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A Southwest Oncology Group study. Med Pediatr Oncol 16:312-319, 1988
    • (1988) Med Pediatr Oncol , vol.16 , pp. 312-319
    • Vaughn, C.1    Green, S.2    O'Bryan, R.3
  • 16
    • 0024999743 scopus 로고
    • Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study
    • Nielsen D, Dombernowsky P, Skovsgaard T, et al: Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study. Ann Oncol 1:275-280, 1990
    • (1990) Ann Oncol , vol.1 , pp. 275-280
    • Nielsen, D.1    Dombernowsky, P.2    Skovsgaard, T.3
  • 17
    • 0026062132 scopus 로고
    • A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients
    • Group FES
    • Group FES: A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. J Clin Oncol 9:305-312, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 305-312
  • 18
    • 0031759089 scopus 로고    scopus 로고
    • Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women
    • Fossati R, Confalonieri C, Torri V, et al: Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women. J Clin Oncol 16:3439-3460, 1998
    • (1998) J Clin Oncol , vol.16 , pp. 3439-3460
    • Fossati, R.1    Confalonieri, C.2    Torri, V.3
  • 19
    • 0018567411 scopus 로고
    • Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy
    • Chlebowski R, Irwin L, Pugh R, et al: Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy. Cancer Res 39:4503-4506, 1979
    • (1979) Cancer Res , vol.39 , pp. 4503-4506
    • Chlebowski, R.1    Irwin, L.2    Pugh, R.3
  • 20
    • 0017104555 scopus 로고
    • Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast
    • Smalley R, Murphy S, Huguley CJ, et al: Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast. Cancer Res 36:3911-3916, 1976
    • (1976) Cancer Res , vol.36 , pp. 3911-3916
    • Smalley, R.1    Murphy, S.2    Huguley, C.J.3
  • 21
    • 0016221645 scopus 로고
    • Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer
    • Baker L, Vaughn C, Al-Sarraf M, et al: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer. Cancer 33:513-518, 1974
    • (1974) Cancer , vol.33 , pp. 513-518
    • Baker, L.1    Vaughn, C.2    Al-Sarraf, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.